How to Boost Third World Science

Scientists in the Third World face many problems, not the least of which is funding. Of necessity, Third World nations cannot yet support science at levels commensurate with those of the developed nations. Meeting the basic needs of their citizens leaves the governments of developing countries with few resources to expend on long-term investment in the form of scientific research. So it often happens in the Third World that university and government research centers are understaffed, equipment i

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Despite these and other obstacles, science is pursued in the Third World, and in some places, like India and Argentina, it is pursued with vigor. As Michael Moravcsik recently noted (THE SCIENTIST, April 20, 1987, p. 11), scientists in the developing countries produce an estimated five percent of the world's scientific literature. Although this represents a small portion of the whole, it is remarkable—given social, economic, and sometimes political adversities—that the output is as high as it is.

Unfortunately, there is too little concern in the wider scientific community and in governmental agencies of the developed nations about the thy-to-day problems confronting scientists in the Third World. Aside from neglect, there is prejudice as well. Some scientists in the developed countries wrongly dismiss work in the Third World as being of universally low quality.

In this issue Philip W. Anderson mentions that recent and highly important work in superconducting materials ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies